Talia K. Ben-Jacob MD, MSc, is the Division Head of Critical Care Medicine in the Department of Anesthesiology at Cooper University Hospital (CUH) and Associate  Professor of Anesthesiology at Cooper Medical School of Rowan University (CMSRU). She received her BS degree and MSc degree from Cornell University. She graduated from the Larner College of Medicine at the University of Vermont College with her MD. She then completed her anesthesiology residency at Cooper University Hospital in Camden, NJ, and critical care medicine fellowship at Barnes-Jewish Hospital/Washington University in St. Louis, MO. She returned to Cooper University Hospital after fellowship graduation where she currently practices a mix of anesthesiology and critical care in a multidisciplinary intensive care unit. She has been awarded the Department of Anesthesiology Resident Champion Award in 2017, 2018, and 2019. She was also the recipient of the 2019 Cooper University Hospital Junior Faculty of the Year Award.

Dr. Ben-Jacob is also very active in her professional societies. She is a member of the SOCCA Education Committee and Research Committee. She is the founding Co-Chair of the Society of Critical Care Medicine Women in Critical Care Knowledge and Education group as well as member-at-large of Anesthesiology Section Steering Committee. Dr. Ben-Jacob also currently serves on the American Society of Anesthesiologists (ASA) Committee on Critical Care Medicine and Committee on Young Physicians. During her tenure on these committees, Dr. Ben-Jacob was chair of the revision of the Anesthesia-ACLS: First Response to Circulatory Crisis in the OR online CME module, a joint ASA/SOCCA initiative. In addition to her active roles in professional organizations, she is very involved in her hospital system and medical school. She is also a mother to three young amazing individuals.

My research in the laboratory is on pulmonary developmental pathology, with a primary focus on hyperoxia-induced injury and resolution/repair in developing lungs. Using a variety of ante- and/or post-natal animal models of experimental bronchopulmonary dysplasia (BPD) and hyperoxia-induced acute lung injury (HALI), we study the mechanisms of molecular mediators and signaling pathways of inflammation, alveolarization and vascularization contribution to the disease phenotypes of HALI and BPD. The ultimate aim of the research laboratory is to be able to translate our work into a better understanding of the pathogenesis of HALI and BPD to allow improved targeting of therapeutic interventions. We have long-standing collaborations with physicians and scientists from various Universities and Pharmaceutical companies. Our long-term goal is to identify drug candidates for HALI and BPD. My other research interests include Neonatal Sepsis, BPD-associated Pulmonary Hypertension and use of “OMICS” (genomics, transcriptomics, proteomics, metabolomics and microbiomics) approaches relevant to premature neonates.

I am proud to have been named to SJ Magazine's list of "Top Doctors for Children 2021" in Neonatology.

Publications

Das P, Curstedt T, Agarwal B, Prahaladan VM, Ramirez J, Bhandari S, Syed MA, Salomone F, Casiraghi C, Pelizzi N, Bhandari V. Small Molecule Inhibitor Adjuvant Surfactant Therapy Attenuates Ventilator- and Hyperoxia-Induced Lung Injury in Preterm Rabbits. Front Physiol. 2020 Apr 9;11:266. doi: 10.3389/fphys.2020.00266. eCollection 2020.

Gilfillan M, Das P, Shah D, Alam MA, Bhandari V. Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitigation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia. Respir Res. 2020 Apr 22;21(1):92. doi: 10.1186/s12931-020-01353-9.

Alam MA, Betal SGN, Aghai ZH, Bhandari V. Hyperoxia causes miR199a-5p-mediated injury in the developing lung. Pediatr Res. 2019 Nov;86(5):579-588. doi: 10.1038/s41390-019-0524-3. Epub 2019 Aug 8.

For a complete list, please see:
https://www.ncbi.nlm.nih.gov/pubmed/?term=bhandari%2C+vineet

Bert Bieler, MD, is the outgoing president of the Philadelphia Endocrine Society, and previously served as the society's vice president. His interests include diabetes management, weight loss management, and thyroid disease management, including thyroid nodule biopsies.

Dr. Kelly Bolkus grew up in southern New Jersey and obtained her undergraduate degree from Rutgers Camden as a biology major. After college, she worked as an ED technician for a few years before deciding to pursue a career in medicine. She completed her medical education at UMDNJ-SOM followed by an anesthesia residency at Cooper University Hospital.

Dr. Bolkus serves on the regional and pediatric anesthesia teams. She enjoys teaching medical students, SRNAs, and residents on a daily basis. In her free time she enjoys running, spending time with family, and watching anime.